Skip to main content

Day: October 7, 2025

Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million

FLORHAM PARK, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB) (“Cellectar” or the “company”), a late-stage biotechnology company focused on the discovery and development of drugs for the treatment of cancer, today announced an agreement between the company and several institutional investors to exercise certain existing warrants (the “Existing Warrants”) for gross proceeds to the company of approximately $5.8 million prior to deducting placement agent fees and estimated offering expenses. Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent for this transaction. The Existing Warrants were issued by the company on October 25, 2022, July 21, 2024, and July 2, 2025. An aggregate of 1,048,094 Existing Warrants were exercised. The shares of common stock issuable upon exercise of...

Continue reading

TRWD Confirms Adult Entertainment and Hospitality Division Progress as Alan Chang Leads Expansion Effort

Through its newly formed division TRWD and the Peppermint Hippo are acquiring underperforming gentlemen’s clubs, remodeling them into modern “mini-Vegas” venues, and rolling them into a fully SEC-reporting public company.This video explains the bold strategyNEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) — Tradewinds Universal, Inc. (OTCID: TRWD), a fully reporting public holding company, today provided an update on the progress of its transaction with Peppermint Hippo, outlining continued advancements toward closing and operational integration under the leadership of Alan Chang, founder and CEO of Peppermint Hippo and Director of TRWD’s Adult Hospitality Division. Following the previously announced agreement between Tradewinds Universal and Peppermint Hippo, the two companies have made significant progress in aligning...

Continue reading

Barfresh Completes Strategic Acquisition of Arps Dairy

Transaction Positions Company for Accelerated Growth with Enhanced Manufacturing Capabilities and Operational Synergies Company on Track to Deliver Fiscal Year 2025 Revenue of $14.5 Million to $15.5 Million Acquisition Expected to More Than Double Revenue to $30 Million to $35 Million and Enhance Profitability in Fiscal Year 2026 LOS ANGELES, Oct. 07, 2025 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced that it has completed the previously announced acquisition of all outstanding capital stock of Arps Dairy, Inc., an Ohio-based dairy processing company. The transaction was completed primarily for approximately $1.3 million in debt repayment, funded through an expansion of the Company’s existing line of credit. The...

Continue reading

MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets

MAIA’s Board of Directors authorizes holdings of up to 90% of the Company’s liquid assets in cryptocurrencies (BTC), Ethereum (ETH), and USD Coin (USDC) CHICAGO, Oct. 07, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced its launch of a new digital asset treasury strategy focused on top-tier cryptocurrency assets. MAIA’s Board of Directors has authorized holdings of up to 90% of the Company’s liquid assets in various cryptocurrencies. Corporate officers are authorized to purchase and sell Bitcoin (BTC), Ethereum (ETH), and USD Coin (USDC) initially. Management will regularly consult with the Board on cryptocurrency transactions and holdings, cybersecurity procedures,...

Continue reading

Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy

MELBOURNE, Australia, Oct. 07, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing treatments for recurring and metastatic cancer, announced its fiscal year-end update following the filing of its annual 10-K report with the Securities and Exchange Commission on September 29, 2025. The reporting period concluded on June 30, 2025. As a result of significant changes to its financial position during the year, the Company was able to complete an initial public offering and uplisting to Nasdaq on August 14, 2025. These developments are expected to support future operational and research activities. James Nathanielsz, Propanc’s CEO stated, “The Company is focused on advancing our lead therapeutic candidate and further building our intellectual property...

Continue reading

Powering Possibilities: Itron Unveils Full Conference Lineup for Itron Inspire 2025

CEO of Gainesville Regional Utilities to Deliver Keynote at Itron’s Premier Event LIBERTY LAKE, Wash., Oct. 07, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, unveiled the speaker lineup for its premier customer-focused event, Itron Inspire 2025, which will be held in Orlando, FL, Oct. 24-30, 2025. The conference will gather industry leaders across electricity, water, gas, IIoT and smart cities to drive more intelligent and sustainable resource management. “Utilities and cities are navigating an era of unprecedented complexity with growing and changing demand, aging infrastructure, rising consumer expectations, physical and cybersecurity threats, extreme weather and sustainability initiatives. Addressing these challenges requires a new way of...

Continue reading

Alpha Modus Escalates Patent Enforcement Offensive Targeting Global Retail Tech Giants

CORNELIUS, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) — Alpha Modus, Corp., the subsidiary of Alpha Modus Holdings, Inc. (NASDAQ: AMOD) has filed new patent infringement lawsuits in the U.S. District Court for the Eastern District of Texas against Sensormatic Electronics LLC and Johnson Controls International PLC, as well as against Navori SA and meldCX Pty Ltd—marking a decisive escalation in the company’s ongoing campaign to enforce its intellectual property across the global retail technology landscape.Alpha Modus’s complaints allege that these multi-national companies are unlawfully deploying Alpha Modus’s patented artificial intelligence systems that monitor and analyze real-time consumer behavior, sentiment, and product interaction—technologies that have become foundational to modern in-store analytics, retail media, and digital...

Continue reading

Disclosure of total number of voting rights and number of shares in the capital at September 30, 2025

French limited company (Société anonyme) with registered capital of 106,640,982.60 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at September 30, 2025 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF’s General Regulations:Total number of shares 533,204,913Number of real voting rights (excluding treasury shares) 533,204,913Theoretical number of voting rights (including treasury shares*)(*) pursuant to article 223-11 of the AMF’s General Regulations 533,204,913About L’Oréal  For 115 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers...

Continue reading

CPS Technologies Corp. Announces Pricing of $9.0 Million Public Offering of Common Stock

NORTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) — CPS Technologies Corp. (NASDAQ: CPSH) (“CPS” or the “Company”), today announced the pricing of its previously announced underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $3.00 per share of common stock, for gross proceeds of approximately $9.0 million, before deducting underwriting discounts and commissions and offering expenses. The Company intends to use the net proceeds from this offering for general corporate purposes, which may include working capital, capital expenditures, the repayment or refinancing of existing indebtedness and other investments. Roth Capital Partners is acting as the sole book-running manager for the offering. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional...

Continue reading

Village Super Market, Inc. Reports Results for the Fourth Quarter Ended July 26, 2025

SPRINGFIELD, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) — Village Super Market, Inc. (NSD-VLGEA) today reported its results of operations for the fourth quarter ended July 26, 2025. Fourth Quarter HighlightsNet income of $15.5 million, an increase of 1% compared to $15.4 million in the fourth quarter of the prior yearAdjusted net income of $15.6 million, a decrease of 8% compared to adjusted net income of $16.9 million in the fourth quarter of the prior yearSales increased 3.7% and same store sales increased 1.6%Same store digital sales increased 11%Year-To-Date Fiscal 2025 HighlightsNet income of $56.4 million, an increase of 12% compared to $50.5 million in the prior year-to-date periodAdjusted net income of $56.9 million, an increase of 8% compared to adjusted net income of $52.6 million in the prior year-to-date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.